홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Anisodamine

HCID 6918612
새 반응
인쇄

데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다

기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
55869-99-3
표준 SMILES
CN1[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@@H](O)C2
InChIKey
WTQYWNWRJNXDEG-RBZJEDDUSA-N
분자식
C17H23NO4
평균 분자량
305.4 g/mol
단동위원소 질량
305.16270822

개요

Anisodamine has been investigated for the treatment of Intestinal Diseases.

이름 및 식별자

우선 이름
Anisodamine
IUPAC
[(1R,3S,5R,6S)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2S)-3-hydroxy-2-phenylpropanoate
영어명
Anisodamine
분자식
C17H23NO4
분자량
305.37

이름 및 동의어

anisodamine55869-99-3Hyoscyamine, 6-hydroxy-01343Q8EL8[(1R,3S,5R,6S)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2S)-3-hydroxy-2-phenylpropanoateDTXSID301025872(1R,3S,5R,6S)-6-HYDROXY-8-METHYL-8-AZABICYCLO[3.2.1]OCTAN-3-YL (2S)-3-HYDROXY-2-PHENYLPROPANOATEalpha-(Hydroxymethyl)benzeneacetic acid 6-hydroxy-8-methyl-8-azabicyclo(3.2.1)oct-3-yl esterBenzeneacetic acid, alpha-(hydroxymethyl)-, (1R,3S,5R,6S)-6-hydroxy-8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, (alphaS)-DTXSID00425118((1R,3S,5R,6S)-6-hydroxy-8-methyl-8-azabicyclo(3.2.1)octan-3-yl) (2S)-3-hydroxy-2-phenylpropanoate(1R,3S,5R,6S)-6-hydroxy-8-methyl-8-azabicyclo(3.2.1)octan-3-yl (2S)-3-hydroxy-2-phenylpropanoate
이름 더 보기
6-hydroxyhyoscyamineaceanisodaMine(-)-AnisodamineAtropine impurity E6-hydroxy-hyoscyaminApoatropine Impurity E6-β-HydroxyhyoscyamineScopolamine Impurity 66-beta-hydroxyhyoscyamineHyoscyamine EP Impurity C
RefChem:915889(-)-6beta-hydroxyhyoscyamineDTXCID50375952DTXCID601510125637-239-0Anisodamine, (+/-)-Raceanisodamine [WHO-DD]U5AC4ZPQ36

물성

구조 계산 물성보충 중

XLogP
0.9
극성 표면적
70 Ų
수소 결합 공여자 수
2
수소 결합 수용자 수
5
회전 가능 결합 수
5
무거운 원자 수
22
형식 전하
0
복잡도
396

실험 및 물리화학적 성질

DrugsPharmaceuticals -> Listed in ZINC15
Collision Cross Section172.34 Ų [M+H-H2O]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

물리화학적 성질

녹는점
62 · 62-63 °C
끓는 점
474.6 · 474.6±45.0 °C(Predicted)
밀도
1.27 · 1.27
저장 조건
room temp
용해도
2 O: · H2O: ≥5mg/mL
산도 계수 (pKa)
14.12 · 14.12±0.10(Predicted)
물리적 상태
가루
색상
흰색에서 베이지색
수용성
2 O: · H2O: ≥5mg/mL
InChI
1S/C17H23NO4/c1-18-12-7-13(9-15(18)16(20)8-12)22-17(21)14(10-19)11-5-3-2-4-6-11/h2-6,12-16,19-20H,7-10H2,1H3/t12-,13-,14+,15+,16-/m0/s1
InChIKey
WTQYWNWRJNXDEG-RBZJEDDUSA-N
SMILES
CN1[C@H]2C(O)C[C@@H]1C[C@H](OC(C(CO)C3=CC=CC=C3)=O)C2

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 6건

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P264+P265, P270, P280, P301+P317, P305+P351+P338, P330, P337+P317, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 38 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

유해성 정보

Hazard Classes and Categories · 2건

Acute Tox. 4 (100%)

Acute Tox. 4 (100%)

안전 데이터

wgk
3
Hazard Classifications
Acute Tox. 4 OralEye Irrit. 2
스토리지 클래스
11 - Combustible Solids

화학 및 산업

약리 정보

MeSH Pharmacological Classification · 6건

Drugs that selectively bind to and activate alpha adrenergic receptors.

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.

Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief.

Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS.

Drugs used to cause dilation of the blood vessels.

응용 분야

용도6S-Hydroxyhyoscyamine is a derivative of Hyoscyamine (H674300), a natural compound that has inhibitory activity against cholinesterases.

일반 설명Racemic mixture of diastereomers.

관련 반응

1건
반응 기록 만들기
HRID 1086417 반응식
HRID 1086417반응물로

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트

데이터베이스 식별자

CAS
55869-99-3、85760-60-7
PubChem CID
6918612
DTXSID
DTXSID301025872
ChEMBL
CHEMBL2165224
UNII
01343Q8EL8、U5AC4ZPQ36
EC Number
637-239-0、695-410-5
Nikkaji
J33.369G